Percutaneous coronary intervention can reduce the risk of severe cardiovascular events in treating left main coronary artery disease, reveals a new study.
A meta-analysis of several trials and nearly 5,000 patients revealed no differences in mortality between the two treatments.
Surprising Trends Found in Cause of Long-Term Death After Percutaneous Coronary Intervention
More people with known coronary heart disease die because of other conditions like cancer, lung and neurological diseases, rather than heart disease as compared to 20 years ago, reveals a Mayo Study.
Advertisement
‘Percutaneous coronary intervention is better than coronary artery bypass grafting in reducing the risk of severe cardiovascular events.’
Tweet it Now
The finding is significant when it comes to selecting the form of treatment: percutaneous coronary intervention is less burdensome on the patient, as it does not require long-term hospitalisation and enables rapid return to work.
The prognosis of left main coronary artery disease is worse than in any other form of coronary artery disease. The treatment options include percutaneous coronary intervention and coronary artery bypass grafting.
![Systolic Blood Pressure is a Useful Predictor for Patients Experiencing STEMI]( "Systolic Blood Pressure is a Useful Predictor for Patients Experiencing STEMI")
STEMI is one type of myocardial infarction in which a part the heart muscle (myocardium) has died due to the obstruction of blood supply to the area.
In European and American treatment guidelines, coronary artery bypass grafting is generally regarded as the first-line treatment for severe left main coronary artery disease. However, some studies have suggested that percutaneous coronary intervention with drug-releasing stent implantation would also be a recommendable course of treatment in the severe form of the disease, but the evidence has been inconsistent.
A new study by investigators from the University of Eastern Finland and Oulu University Hospital compared percutaneous coronary intervention with drug-releasing stent implantation and coronary artery bypass grafting in the treatment of left main coronary artery disease.
The authors pooled evidence from six comparable, randomised, controlled trials involving 4,700 people.
The researchers analysed all available randomized studies among patients who had undergone percutaneous coronary intervention or coronary artery bypass grafting, comparing their risk of all-cause mortality, major adverse cardiac and cerebrovascular events, and other cardiovascular events at time points of 30 days, one year and three years after surgery.
There were no differences between the treatments as regards the risk of death, or cardiac or cerebrovascular events. Percutaneous coronary intervention patients needed repetitive interventions more often over the years.
According to the researchers, the findings suggest that percutaneous coronary intervention with drug-releasing stent implantation should be more frequently considered as a treatment option for patients suffering from left main coronary artery disease.
There are no differences in mortality between patients of percutaneous coronary intervention and patients undergoing coronary artery bypass grafting, and as percutaneous coronary intervention is less burdensome on the patient both from the viewpoint of quality of life and functional capacity, it is an option worth considering.
Source: Eurekalert
Systolic Blood Pressure is a Useful Predictor for Patients Experiencing STEMI
STEMI is one type of myocardial infarction in which a part the heart muscle (myocardium) has died due to the obstruction of blood supply to the area.
Advertisement
In European and American treatment guidelines, coronary artery bypass grafting is generally regarded as the first-line treatment for severe left main coronary artery disease. However, some studies have suggested that percutaneous coronary intervention with drug-releasing stent implantation would also be a recommendable course of treatment in the severe form of the disease, but the evidence has been inconsistent.
A new study by investigators from the University of Eastern Finland and Oulu University Hospital compared percutaneous coronary intervention with drug-releasing stent implantation and coronary artery bypass grafting in the treatment of left main coronary artery disease.
The authors pooled evidence from six comparable, randomised, controlled trials involving 4,700 people.
The researchers analysed all available randomized studies among patients who had undergone percutaneous coronary intervention or coronary artery bypass grafting, comparing their risk of all-cause mortality, major adverse cardiac and cerebrovascular events, and other cardiovascular events at time points of 30 days, one year and three years after surgery.
There were no differences between the treatments as regards the risk of death, or cardiac or cerebrovascular events. Percutaneous coronary intervention patients needed repetitive interventions more often over the years.
According to the researchers, the findings suggest that percutaneous coronary intervention with drug-releasing stent implantation should be more frequently considered as a treatment option for patients suffering from left main coronary artery disease.
There are no differences in mortality between patients of percutaneous coronary intervention and patients undergoing coronary artery bypass grafting, and as percutaneous coronary intervention is less burdensome on the patient both from the viewpoint of quality of life and functional capacity, it is an option worth considering.
Source: Eurekalert
Aspirin may Influence Heart Problems After Normal Surgery
Previous stent or angioplasty patients can experience heart problems after a normal surgery with peri-operative aspirin therapy
Advertisement
 New ESC Guidelines Help Treat STEMI PatientsNew guidelines published provide a clear definition of when to start the clock for the 90 minute target to treat patients with percutaneous coronary intervention (PCI). | Advertisement
|
Advertisement
Recommended Reading
Latest Heart Disease News
In middle-age patients, CT scan identifies people who may benefit from drugs to decrease heart disease risk, stated study.
Researchers analyzed the link between muscle strength and the risk of developing heart failure in patients who had a heart attack without prior history of complications.
Heart health scores for gay and bisexual men were 2.72 and 0.83 points superior, respectively, compared to heterosexual men.
Research suggests that individuals with robust leg muscles have a reduced risk of developing heart failure following a heart attack.
Is marijuana bad for your heart? Yes, marijuana use may put you at a higher risk of developing peripheral artery disease (PAD). Check out the impact of marijuana use on health.